shengnuo biotechnology: As of June 30, 2021, the company has 32 authorized invention patents, 9 utility model patents, and 2 international PCT broadcast articles

Every time through the AI newsletter, investors ask questions on the investor interactive platform: hello, secretary of the board. Will your company have new patents or new pharmaceutical products on the market recently?

shengnuo biotechnology (688117.SH) stated on the investor interactive platform on September 22 that as of June 30, 2021, the company has 32 authorized invention patents, 9 utility model patents, and 2 international PCT patents. At the same time, the company will continue to promote the relevant research and development work of the products under research. If there is any progress in the research and development of new drugs and patents, please pay attention to the relevant announcements disclosed by the company on the Shanghai Stock Exchange website and designated information disclosure media.

Other Polypeptide APIs Products

peptide synthesis companies

Polypeptide APIs Products
US-DMF LIST
Beauty peptides
Chinese cGMP APIs
Mexico Registered APIs
Research Peptide APIs for Regulatory Market
Polypeptide Preparation
Kaijie bio medicine Peptide APIs